Literature DB >> 19708072

Four- and five-color flow cytometry analysis of leukocyte differentiation pathways in normal bone marrow: a reference document based on a systematic approach by the GTLLF and GEIL.

Christine Arnoulet1, Marie C Béné, Françoise Durrieu, Jean Feuillard, Chantal Fossat, Bernard Husson, Hélène Jouault, Marc Maynadié, Francis Lacombe.   

Abstract

BACKGROUND: The development of multiparameter flow cytometry (FCM) and increasingly sophisticated analysis software has considerably improved the exploration of hematological disorders. These tools have been widely applied in leukaemias, lymphomas, and myelodysplasias, yet with very heterogeneous approaches. Consequently, there is no extensive reference document reporting on the characteristics of normal human bone marrow (BM) in multiparameter FCM. Here, we report a reference analysis procedure using relevant antibody combinations in normal human BM.
METHODS: A first panel of 23 antibodies, constructed after literature review, was tested in four-color combinations (including CD45 in each) on 30 samples of BM. After evaluation of the data, a second set of 22 antibodies was further applied to another 35 BM samples. All list-modes from the 65 bone marrow samples were reviewed collectively. A systematised protocol for data analysis was established including biparametric representations and color codes for the three major lineages and undifferentiated cells.
RESULTS: This strategy has allowed to obtain a reference atlas of relevant patterns of differentiation antigens expression in normal human BM that is available within the European LeukemiaNet. This manuscript describes how this atlas was constructed.
CONCLUSIONS: Both the strategy and atlas could prove very useful as a reference of normality, for the determination of leukemia-associated immunophenotypic patterns, analysis of myelodysplasia and, ultimately, investigation of minimal residual disease in the BM.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19708072     DOI: 10.1002/cyto.b.20484

Source DB:  PubMed          Journal:  Cytometry B Clin Cytom        ISSN: 1552-4949            Impact factor:   3.058


  16 in total

1.  The European LeukemiaNet: achievements and perspectives.

Authors:  Rüdiger Hehlmann; David Grimwade; Bengt Simonsson; Jane Apperley; Michele Baccarani; Tiziano Barbui; Giovanni Barosi; Renato Bassan; Marie C Béné; Ute Berger; Thomas Büchner; Alan Burnett; Nicolas C P Cross; Theo J M de Witte; Hartmut Döhner; Hervé Dombret; Hermann Einsele; Georg Engelich; Robin Foà; Christa Fonatsch; Nicola Gökbuget; Elaine Gluckman; Alois Gratwohl; Francois Guilhot; Claudia Haferlach; Thorsten Haferlach; Michael Hallek; Jörg Hasford; Andreas Hochhaus; Dieter Hoelzer; Jean-Jaques Kiladjian; Boris Labar; Per Ljungman; Ulrich Mansmann; Dietger Niederwieser; Gert Ossenkoppele; José M Ribera; Harald Rieder; Hubert Serve; Petra Schrotz-King; Miguel A Sanz; Susanne Saussele
Journal:  Haematologica       Date:  2010-11-03       Impact factor: 9.941

Review 2.  Is There a Role for Flow Cytometry in the Evaluation of Patients With Myelodysplastic Syndromes?

Authors:  Anna Porwit
Journal:  Curr Hematol Malig Rep       Date:  2015-09       Impact factor: 3.952

3.  Noncanonical Mechanisms for Direct Bone Marrow Generating Ang II (Angiotensin II) Predominate in CD68 Positive Myeloid Lineage Cells.

Authors:  Tomohisa Yamashita; Sarfaraz Ahmad; Kendra N Wright; Drew J Roberts; Jessica L VonCannon; Hao Wang; Leanne Groban; Louis J Dell'Italia; Carlos M Ferrario
Journal:  Hypertension       Date:  2019-12-09       Impact factor: 10.190

4.  Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes-proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS.

Authors:  A Porwit; A A van de Loosdrecht; P Bettelheim; L Eidenschink Brodersen; K Burbury; E Cremers; M G Della Porta; R Ireland; U Johansson; S Matarraz; K Ogata; A Orfao; F Preijers; K Psarra; D Subirá; P Valent; V H J van der Velden; D Wells; T M Westers; W Kern; M C Béné
Journal:  Leukemia       Date:  2014-06-12       Impact factor: 11.528

5.  Bone marrow oxidative stress and specific antioxidant signatures in myelodysplastic syndromes.

Authors:  Frederic Picou; Christine Vignon; Christelle Debeissat; Sébastien Lachot; Olivier Kosmider; Nathalie Gallay; Amelie Foucault; Marie-Hélène Estienne; Noémie Ravalet; Marie C Bene; Jorge Domenech; Emmanuel Gyan; Michaela Fontenay; Olivier Herault
Journal:  Blood Adv       Date:  2019-12-23

Review 6.  Mixed Phenotype/Lineage Leukemia: Has Anything Changed for 2021 on Diagnosis, Classification, and Treatment?

Authors:  Marie C Béné; Anna Porwit
Journal:  Curr Oncol Rep       Date:  2022-04-05       Impact factor: 5.945

7.  Downregulation of Blood Monocyte HLA-DR in ICU Patients Is Also Present in Bone Marrow Cells.

Authors:  Valérie Faivre; Anne-Claire Lukaszewicz; Didier Payen
Journal:  PLoS One       Date:  2016-11-28       Impact factor: 3.240

8.  Mixed Phenotype Acute Leukemia with Two Immunophenotypically Distinct B and T Blasts Populations, Double Ph (+) Chromosome and Complex Karyotype: Report of an Unusual Case.

Authors:  Samah A Kohla; Ahmad Al Sabbagh; Halima El Omri; Firyal A Ibrahim; Ivone B Otazu; Hessa Alhajri; Mohamed A Yassin
Journal:  Clin Med Insights Blood Disord       Date:  2015-09-21

9.  Immunophenotype of normal and myelomatous plasma-cell subsets.

Authors:  Nelly Robillard; Soraya Wuillème; Philippe Moreau; Marie C Béné
Journal:  Front Immunol       Date:  2014-03-31       Impact factor: 7.561

10.  Novel Strategy for Phenotypic Characterization of Human B Lymphocytes from Precursors to Effector Cells by Flow Cytometry.

Authors:  Giovanna Clavarino; Noémie Delouche; Claire Vettier; David Laurin; Martine Pernollet; Tatiana Raskovalova; Jean-Yves Cesbron; Chantal Dumestre-Pérard; Marie-Christine Jacob
Journal:  PLoS One       Date:  2016-09-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.